# DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement

- Company: DAVITA INC. (DVA)
- Period: 2026-07-01 to 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-29, accession number 0000927066-26-000134
- Page: https://plicit.ai/financials/dva/fy2026-q3-income-statement
- Chart image: https://plicit.ai/charts/dva-fy2026-q3-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2026-07-01 through 2026-09-30. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 3,578,126,000 US dollars
- **Total operating expenses**: 3,078,871,000 US dollars
- **Operating income**: 499,255,000 US dollars
- **Other income (expense), net (calculated)**: negative 140,548,000 US dollars
- **Income before income taxes**: 358,707,000 US dollars
- **Income tax expense**: 89,318,000 US dollars
- **Net income**: 269,389,000 US dollars
- **Dialysis patient service revenues**: 3,408,266,000 US dollars
- **Other revenues**: 169,860,000 US dollars
- **Patient care costs**: 2,451,047,000 US dollars
- **General and administrative**: 408,697,000 US dollars
- **Depreciation and amortization**: 165,188,000 US dollars
- **Equity investment income, net**: negative 8,237,000 US dollars
- **Goodwill and other asset impairment charges**: 62,176,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.

## Chart details: Revenue by Business Segment (4 categories)

- Page: https://plicit.ai/financials/dva/fy2026-q3-income-statement/revenue-by-business-segment-4-categories
- Chart image: https://plicit.ai/charts/dva-fy2026-q3-revenue-by-business-segment-4-categories-sankey.png

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 3,578,126,000 US dollars
- **Total operating expenses**: 3,078,871,000 US dollars
- **Operating income**: 499,255,000 US dollars
- **Other income (expense), net (calculated)**: negative 140,548,000 US dollars
- **Income before income taxes**: 358,707,000 US dollars
- **Income tax expense**: 89,318,000 US dollars
- **Net income**: 269,389,000 US dollars
- **U S Dialysis And Related Lab Services with Intersegment**: 3,050,478,000 US dollars
- **Other Operating Segments with Intersegment**: 551,766,000 US dollars
- **Patient care costs**: 2,451,047,000 US dollars
- **General and administrative**: 408,697,000 US dollars
- **Depreciation and amortization**: 165,188,000 US dollars
- **Equity investment income, net**: negative 8,237,000 US dollars
- **Goodwill and other asset impairment charges**: 62,176,000 US dollars
- **Revenue before reconciliation (calculated)**: 3,602,244,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **U. S. Dialysis And Related Lab Services - Intersegment Elimination**: negative 22,008,000 US dollars. Reported reconciliation to consolidated revenue.
- **Other Operating Segment - Intersegment Elimination**: negative 2,110,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.

## Chart details: Revenue by Business Segment (2 categories)

- Page: https://plicit.ai/financials/dva/fy2026-q3-income-statement/revenue-by-business-segment-2-categories
- Chart image: https://plicit.ai/charts/dva-fy2026-q3-revenue-by-business-segment-2-categories-sankey.png

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 3,578,126,000 US dollars
- **Total operating expenses**: 3,078,871,000 US dollars
- **Operating income**: 499,255,000 US dollars
- **Other income (expense), net (calculated)**: negative 140,548,000 US dollars
- **Income before income taxes**: 358,707,000 US dollars
- **Income tax expense**: 89,318,000 US dollars
- **Net income**: 269,389,000 US dollars
- **U. S. Dialysis And Related Lab Services**: 3,028,470,000 US dollars
- **Other Operating Segment**: 549,656,000 US dollars
- **Patient care costs**: 2,451,047,000 US dollars
- **General and administrative**: 408,697,000 US dollars
- **Depreciation and amortization**: 165,188,000 US dollars
- **Equity investment income, net**: negative 8,237,000 US dollars
- **Goodwill and other asset impairment charges**: 62,176,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.

## Chart details: Revenue by Health Care Revenue Source

- Page: https://plicit.ai/financials/dva/fy2026-q3-income-statement/revenue-by-health-care-revenue-source
- Chart image: https://plicit.ai/charts/dva-fy2026-q3-revenue-by-health-care-revenue-source-sankey.png

Income statement for 2026-07-01 through 2026-09-30. View: Health Care Organization, Revenue Sources. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 3,578,126,000 US dollars
- **Total operating expenses**: 3,078,871,000 US dollars
- **Operating income**: 499,255,000 US dollars
- **Other income (expense), net (calculated)**: negative 140,548,000 US dollars
- **Income before income taxes**: 358,707,000 US dollars
- **Income tax expense**: 89,318,000 US dollars
- **Net income**: 269,389,000 US dollars
- **Medicare and Medicare Advantage**: 1,756,098,000 US dollars
- **Medicaid and Managed Medicaid**: 228,173,000 US dollars
- **Other Government Payors**: 342,647,000 US dollars
- **Commercial Payors**: 1,103,356,000 US dollars
- **Undisclosed (calculated)**: 147,852,000 US dollars
- **Patient care costs**: 2,451,047,000 US dollars
- **General and administrative**: 408,697,000 US dollars
- **Depreciation and amortization**: 165,188,000 US dollars
- **Equity investment income, net**: negative 8,237,000 US dollars
- **Goodwill and other asset impairment charges**: 62,176,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.

## Key Takeaways

- A $62.18 M China write-down pushed operating income down 1.3% to $499.26 M despite 4.6% sales growth.
- Diluted earnings per share leapt 67% to $3.40 as the average diluted share count fell 11%.
- Outside partners took $46.46 M of profit, down from $89.92 M, as they shared the China charge.
- Operating profit covered interest 3.3 times, against 3.4 times a year earlier.

## The Unvarnished Truth

### DaVita's per-share earnings leapt 67% while its operating profit slipped

DaVita wrote $62.18 M off its business in China this quarter, and that charge decides the headline. Operating income slipped 1.3% to $499.26 M even as sales grew 4.6% to $3.58 B. Add the charge back and operating income would have been $561.43 M, 11% above a year earlier. Yet diluted earnings per share leapt 67%, to $3.40, from $2.04. How does a company post a lower operating profit and a far richer profit per share in the same quarter? The answer runs through its partners and its share count.

Start with partners. Outside owners of DaVita's subsidiaries took $46.46 M of profit, down from $89.92 M a year earlier. Management says $34 million of the China impairments fell on those minority holders. Net income attributable to DaVita rose 48% to $222.93 M. Then shares. The diluted share count averaged 11% fewer than a year before, after heavy buybacks, so each remaining share claimed more. Below the operating line, other income was $9.47 M against a $41.26 M loss a year earlier.

For shareholders the quarter's gain is real but narrow: it comes from fewer shares, a smaller partner cut and a turn in other income, not from a stronger core. Operating profit covered interest 3.3 times, against 3.4 times a year earlier. The share of pre-tax profit paid in tax rose to 24.9% from 22.2%. Management ties the rise from the second quarter mainly to a goodwill charge that is not tax-deductible. The filing says China remains at risk of further goodwill impairment. Watch the operating line, not the per-share line. If the China write-down is set aside, is DaVita's dialysis engine still growing, or are buybacks doing the heavy lifting?

## Intelligent Insights for Investors

### Did DaVita make a profit this quarter?

Yes. On $3.58 B of sales this quarter, DaVita kept $269.39 M as profit after every cost, interest charge and tax. That is up from $240.25 M a year earlier, though $46.46 M of it belonged to outside partners.

### Is DaVita's profit per share growing faster than its profit?

Yes: diluted earnings per share rose 67% this quarter while profit attributable to DaVita rose 48%. The average diluted share count fell 11%, so each share claimed a bigger slice.

### How much of DaVita's profit belongs to outside owners of its subsidiaries?

About 17%: outside owners of its subsidiaries were due $46.46 M of the $269.39 M it earned this quarter, against 37% a year earlier. Management attributes $34 million of the China impairments to those minority interests.

### Did a lower tax rate drive DaVita's profit growth?

No, taxes worked the other way. The share of pre-tax profit paid in tax rose from 22.2% to 24.9% this quarter, so profit after tax trailed profit before tax.

## Intelligent Insights for Lenders

### Does DaVita earn enough to cover its interest payments?

Yes: its operating profit covered its interest 3.3 times this quarter, against 3.4 times a year earlier. Interest and debt expense came to $150.02 M against $499.26 M of operating income.

## Intelligent Insights for Employees

### What is DaVita's biggest expense?

Patient care costs top the list at $2.45 B this quarter, or $68.50 of every $100 it took in. Next came general and administrative costs of $408.70 M.
